Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 324 Results
Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
February 13, 2025
Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025
February 10, 2025
Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
February 7, 2025
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
February 6, 2025
Palatin Provides Update on Anticipated 2025 Corporate Milestones
January 28, 2025
Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy
December 19, 2024
Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds
December 16, 2024
Page 1 of 33